ATE78518T1 - Verfahren zur diagnose von krankheiten mit einer arthritischen komponente. - Google Patents

Verfahren zur diagnose von krankheiten mit einer arthritischen komponente.

Info

Publication number
ATE78518T1
ATE78518T1 AT86870007T AT86870007T ATE78518T1 AT E78518 T1 ATE78518 T1 AT E78518T1 AT 86870007 T AT86870007 T AT 86870007T AT 86870007 T AT86870007 T AT 86870007T AT E78518 T1 ATE78518 T1 AT E78518T1
Authority
AT
Austria
Prior art keywords
diagnosis
diseases
component
methods
arthritic
Prior art date
Application number
AT86870007T
Other languages
English (en)
Inventor
Raymond A Dep Of Biochemi Dwek
Thomas W Dep Of Bio Rademacher
Road
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ATE78518T1 publication Critical patent/ATE78518T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/827Lectins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electroluminescent Light Sources (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
AT86870007T 1985-01-22 1986-01-21 Verfahren zur diagnose von krankheiten mit einer arthritischen komponente. ATE78518T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/693,075 US4659659A (en) 1985-01-22 1985-01-22 Diagnostic method for diseases having an arthritic component
EP86870007A EP0189388B1 (de) 1985-01-22 1986-01-21 Verfahren zur Diagnose von Krankheiten mit einer arthritischen Komponente

Publications (1)

Publication Number Publication Date
ATE78518T1 true ATE78518T1 (de) 1992-08-15

Family

ID=24783210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86870007T ATE78518T1 (de) 1985-01-22 1986-01-21 Verfahren zur diagnose von krankheiten mit einer arthritischen komponente.

Country Status (14)

Country Link
US (1) US4659659A (de)
EP (1) EP0189388B1 (de)
JP (1) JP2515289B2 (de)
AT (1) ATE78518T1 (de)
AU (1) AU586662B2 (de)
CA (1) CA1272670A (de)
DE (1) DE3686061T2 (de)
DK (1) DK164417C (de)
FI (1) FI88341C (de)
GR (1) GR860167B (de)
IE (1) IE58727B1 (de)
IL (1) IL77666A (de)
NO (1) NO166302C (de)
ZA (1) ZA86442B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component
GB8618443D0 (en) * 1986-07-29 1986-09-03 Univ London Monoclonal antibodies
GB8714270D0 (en) * 1987-06-18 1987-07-22 Williams G R Analysis of carbohydrates
US4791067A (en) * 1987-06-25 1988-12-13 Fisher Scientific Co. Agglutination immunoassay for hapten involving monoclonal antibody of IgA class reagent
CA2016125A1 (en) * 1989-05-19 1990-11-19 Eisai Co., Ltd. Diagnostic drug for rheumatoid arthritis
US5089409A (en) * 1989-09-28 1992-02-18 Monsanto Company Method of increasing specific activity of t-pa
US5100778A (en) * 1989-10-03 1992-03-31 Monsanto Company Oligosaccharide sequencing
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
JP3537535B2 (ja) * 1994-07-14 2004-06-14 株式会社中埜酢店 免疫グロブリンg結合糖鎖構造に基づく臨床検査方法
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5846758A (en) * 1995-11-30 1998-12-08 His Excellency Ghassan I. Shaker Method for diagnosing autoimmune diseases
IL129835A (en) * 1999-05-06 2008-03-20 Ofer Markman Polysaccharide sequencing and structure determination
US20040132131A1 (en) * 2001-11-05 2004-07-08 Ofer Markman Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same
US7407773B2 (en) * 2000-11-03 2008-08-05 Procognia, Ltd. Method for characterizing a carbohydrate polymer
CN1759320B (zh) * 2003-01-14 2014-10-15 Vib研究所 检测肝纤维化的血清标记
WO2004082617A2 (en) * 2003-03-14 2004-09-30 Ppd Biomarker Discovery Sciences, Llc Biological markers for diagnosing rheumatoid arthritis
WO2005015200A1 (ja) * 2003-08-11 2005-02-17 Shionogi Co., Ltd. 血清を用いた簡易疾患診断およびテーラーメイド治療
WO2005059563A2 (en) * 2003-12-18 2005-06-30 Procognia Ltd. Method for analyzing a glycomolecule
US20090226552A1 (en) * 2004-07-22 2009-09-10 Colorado State University Research Foundation Agents and methods for diagnosing osteoarthritis
US7892752B2 (en) * 2005-04-26 2011-02-22 Dwek Raymond A Glycosylation markers for cancer diagnosing and monitoring
US20060269979A1 (en) * 2005-04-26 2006-11-30 Dwek Raymond A High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
US8039208B2 (en) * 2005-04-26 2011-10-18 National Institute For Bioprocessing Research And Training Limited (Nibrt) Automated strategy for identifying physiological glycosylation markers(s)
US8173437B2 (en) * 2005-06-10 2012-05-08 Mannatech, Incorporated Rapid serum sugar biomarker assay of rheumatoid arthritis
BRPI0716959A2 (pt) 2006-09-26 2013-10-29 Infectious Disease Res Inst Composição de vacina contendo adjuvante sintético
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
WO2009078015A2 (en) * 2007-12-18 2009-06-25 Procognia (Israel) Ltd Method and assay for glycosylation pattern detection related to cell state of stem cells
EP3124491B1 (de) 2009-06-05 2019-10-30 Infectious Disease Research Institute Synthetische glucopyranosyl-lipid-adjuvanzien und impfstoffzusammensetzungen sowie pharmazeutische zusammensetzungen die diese enthalten
EP3632463A1 (de) 2011-04-08 2020-04-08 Immune Design Corp. Immunogene zusammensetzungen und verfahren zur verwendung der zusammensetzungen zur induzierung humoraler und zellulärer immunreaktionen
PL2811981T3 (pl) 2012-02-07 2019-09-30 Infectious Disease Research Institute Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
NZ701881A (en) 2012-05-16 2016-10-28 Immune Design Corp Vaccines for hsv-2
MX370573B (es) 2013-04-18 2019-12-17 Immune Design Corp Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP3915579A1 (de) 2013-12-31 2021-12-01 Infectious Disease Research Institute Impfstoffformulierungen mit einzelphiole
WO2017210364A1 (en) 2016-06-01 2017-12-07 Infectious Disease Research Institute Nanoalum particles containing a sizing agent
CN114340665A (zh) 2019-05-25 2022-04-12 传染病研究所 用于对佐剂疫苗乳剂进行喷雾干燥的组合物和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3088875A (en) * 1959-10-27 1963-05-07 Hyland Lab Immunological diagnostics utilizing polystyrene latex particles of 0.15 to 0.25 micron
US4189466A (en) * 1975-09-19 1980-02-19 Technical Research Affiliates, Inc. Detection of rheumatoid factor by antibody sensitized microbial particles
US4213764A (en) * 1978-08-09 1980-07-22 Akzona Incorporated Method for determining immunochemical substances
US4282002A (en) * 1979-09-06 1981-08-04 Akzona Incorporated Sensitized sheep stroma immunoassay for rheumatoid factor
SE447028B (sv) * 1980-06-30 1986-10-20 Erik Audunn Cerven Bestemning av endstaende sackaridgrupper i glykoprotein
US4457865A (en) * 1982-03-08 1984-07-03 Research Corporation Sialic acid specific slug lectin
US4420461A (en) * 1982-05-26 1983-12-13 Ortho Diagnostic Systems Inc. Agglutination-inhibition test kit for detecting immune complexes
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component

Also Published As

Publication number Publication date
DK29086D0 (da) 1986-01-21
DK164417B (da) 1992-06-22
NO860191L (no) 1986-07-23
EP0189388A3 (en) 1988-11-30
CA1272670C (en) 1990-08-14
GR860167B (en) 1986-05-22
EP0189388A2 (de) 1986-07-30
DK164417C (da) 1992-11-16
DE3686061D1 (de) 1992-08-27
IE860176L (en) 1986-07-22
NO166302C (no) 1991-06-26
DE3686061T2 (de) 1993-03-11
AU586662B2 (en) 1989-07-20
FI88341C (fi) 1993-04-26
CA1272670A (en) 1990-08-14
FI88341B (fi) 1993-01-15
JPS61170657A (ja) 1986-08-01
JP2515289B2 (ja) 1996-07-10
IL77666A (en) 1990-12-23
EP0189388B1 (de) 1992-07-22
FI860284A (fi) 1986-07-23
US4659659A (en) 1987-04-21
FI860284A0 (fi) 1986-01-21
IE58727B1 (en) 1993-11-03
NO166302B (no) 1991-03-18
ZA86442B (en) 1986-10-29
DK29086A (da) 1986-07-23
AU5253886A (en) 1986-07-31

Similar Documents

Publication Publication Date Title
ATE78518T1 (de) Verfahren zur diagnose von krankheiten mit einer arthritischen komponente.
DE3852827T2 (de) Test von einer körperflüssigkeit zur messung von knochenresorption.
DE68925481D1 (de) Verfahren zum nachweis von bakterien im harn
DE69636749D1 (de) Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten
DE3776525D1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
DE3889279D1 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B.
DE3163585D1 (en) Method and reagent for the detection of fibrin monomer
AU697417B2 (en) Additive for diagnostic tests for determination of the coagulability of blood, method of reducing the influencing of diagnostic tests by heparin and the use of metal salts for these purposes
DE69123723D1 (de) Diagnostisches verfahren und reagenz für hiv
ATE13600T1 (de) Verfahren zur bestimmung der betalipoproteinfraktion (ldl) in koerperfluessigkeiten.
EP0217768A3 (en) Method and compositions for heparin assays
DE3877493D1 (de) Verfahren und vorrichtung zur volumetrischen bestimmung, verduennung und uebertragung von fluessigkeitsproben.
NO902158D0 (no) Proteinholdig forbindelse for diagnostisk anvendelse.
DE59205827D1 (de) Verfahren zur Bestimmung von Fibrin
ATE269971T1 (de) Verfahren zur prüfung von immunokompetenz
ATE45224T1 (de) Verfahren zur diagnose von a.i.d.s.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time